Risperidone long-acting injectable (microsphere formulation)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Risperidone long-acting injectable (microsphere formulation), covering 2010-07-07 to 2010-07-07. Get the full timeline:
Most recent: Clinical Trial Update: Evaluation of Efficacy and Safety of Long-acting Risperidone Microspheres in Patients With Schizophrenia or Other Psychotic Disorders When Switching From Typical Antipsychotic (Oral/Depot) or Atypical Oral Other Than Risperidone [NA]